22 September 2020 – Geneva, Switzerland – On behalf of the Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF-contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for:

ITB-IDA/GDF-FLD/2020/001, medicines for the treatment of drug-sensitive forms of tuberculosis, and

ITB-IDA/GDF-SLD/2020/002, medicines and related products for the treatment of drug-resistant forms of tuberculosis.

The purpose of the ITBs is to select a panel of suppliers who will enter into a long-term agreement with IDA.

The ITBs are open to bidders whose products have been deemed eligible for inclusion in the tender in compliance with GDF's Quality Assurance policy and procedures. A bid submitted for a product(s) for which the bidder has not received regulatory approval status in accordance with the GDF Quality Assurance policy and procedures shall not be considered for the ITB evaluation.

All bids are subject to the Instructions to Bidders and other provisions, specifications and instructions as contained in this dossier.

The ITB is composed of the following:

1. For ITB-IDA/GDF-FLD/2020/001:

2020 ITB document FLD final [.pdf]

Annex A1 - Technical FLD Bid Response Form. [xlsx]

Annex A2 - Financial FLD Bid Response Form. [xlsx]

Annex B - List and technical specifications of products FLD [.pdf]

Annex C - Response Form for TB medicines registration Revised new version 24_09_2020. [xlsx]

Annex D - IDA model long-term agreement [.pdf]

Annex E - IDA general terms and conditions [.pdf]

Annex F - IDA code of conduct [.pdf]

Annex G - GDF access to supplier information [.pdf]

Annex H - Indicative non-binding estimated quantities FLD [.pdf]

Annex I - GMSD address list [.pdf]

Annex J - Global Drug Facility packaging guidelines [.pdf]

Annex K - ITB checklist. [docx]

Annex L- List of Priority Countries for Registration [.pdf]

Annex X - Form for Requests for Clarifications or Complaints. [docx]

You can also download all ITB-IDA/GDF-FLD/2020/001 files in one .zip file by clicking here.

2. For ITB-IDA/GDF-SLD/2020/002:

2020 ITB document SLD final [.pdf]

Annex A1 - Technical SLD Bid Response Form. [xlsx]

Annex A2 - Financial SLD Bid Response Form. [xlsx]

Annex B - List and technical specifications of products SLD [.pdf]

Annex C - Response Form for TB medicines registration Revised new version 24_09_2020. [xlsx]

Annex D - IDA model long-term agreement [.pdf]

Annex E - IDA general terms and conditions [.pdf]

Annex F - IDA code of conduct [.pdf]

Annex G - GDF access to supplier information [.pdf]

Annex H - Indicative non-binding estimated quantities SLD [.pdf]

Annex I - GMSD address list [.pdf]

Annex J - Global Drug Facility packaging guidelines [.pdf]

Annex K - ITB checklist. [docx]

Annex L- List of Priority Countries for Registration [.pdf]

Annex X - Form for Requests for Clarifications or Complaints. [docx]

You can also download all ITB-IDA/GDF-SLD/2020/002 files in one .zip file by clicking here.

Bidders are requested to quote unit prices in accordance with the following delivery terms: EXW (Ex-Works), FCA (Free Carrier Alongside) and DAP India.

Failure to adhere to the requirements of the ITB may lead to disqualification of the bidder and/or rejection of the bid.

Deadlines for electronic submission of Technical and Financial Bids:

Monday, 5 October 2020, 16:00 IST (India Standard Time) for ITB-IDA/GDF-FLD/2020/001

and

Wednesday, 7 October 2020, 16:00 IST (India Standard Time) for ITB-IDA/GDF-SLD/2020/002.

Faxed or proposals sent through courier are not acceptable.

Public opening of the Financial Bids of both ITBs, accessible remotely, will take place on 14 October 2020 at the following times:

- at 13:30 IST (India Standard Time) for ITB-IDA/GDF-FLD/2020/001

and

- at 14:30 IST (India Standard Time) for ITB-IDA/GDF-SLD/2020/002

Request for clarification – Answers 30 September 2020

Q&A IDA/GDF - FLD/2020/001 - 30 September 2020

Q&A IDA/GDF - SLD/2020/002 - 30 September 2020